Adcock Ingram accused of excessive pricing for kidney medication
SABC News | 03.06.2026 23:23
Pharmaceutical manufacturer Adcock Ingram Critical Care is facing allegations of anti-competitive conduct over the pricing of its kidney failure treatment products.
